Tag: Michael J. Demeure
Pancreatic Neuroendocrine Tumors: A Rare Cancer
From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States. This rare cancer is often…
READ MORE
Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment
Determining Molecular Signature: A Guide for Targeted Therapy of Neuroendocrine Tumors
Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis. This is the cutting-edge…
READ MORE
Steve Jobs, Pancreatic Neuroendocrine Tumor Patient, Talks about Liver Transplant
Steve Jobs, CEO of Apple, is the most well-known member of the carcinoid and neuroendocrine tumor community. He was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant in …
READ MORE
